@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix schem: . @prefix go: . @prefix Protein: . @prefix rgd: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016791 . sub:_2 geneProductOf: rgd:2100; a Protein: . sub:_3 rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:Tretinoin; a rdf:Statement . sub:_4 occursIn: obo:CL_0000062, species:10116; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject chebi:22652; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:\"ascorbic acid\") -> (a(SCHEM:Tretinoin) -> phos(p(RGD:Alpl)))", "a(SCHEM:Tretinoin) -> phos(p(RGD:Alpl))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "Treatment with AA (50 micrograms/ml) alone had no effect on ALP activity but increased RA-induced ALP activity to 6.78 +/- 0.28 mumol/h/mg of protein at 24 h."; prov:wasQuotedFrom pubmed:8410463 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:8410463; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:49.735+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }